Oxygen Is a Drug: Respiratory Failure & Controlled Oxygen
We rarely think of oxygen as a drug, but it is one — with a correct dose, real dangers if misused, and specific indications. The most counter-intuitive lesson in respiratory medicine lives here: in some patients, giving too much oxygen can be harmful. Understanding why unlocks how we treat the failing lung.
Oxygen is so familiar in hospitals that it's easy to forget it's a medicine — one that should be prescribed with a target, a dose (the flow rate and delivery device) and a reason, just like any drug. The lungs exist to do two things: get oxygen INTO the blood, and get carbon dioxide OUT. When they fail at this, it's called respiratory failure, and it comes in two types that matter enormously for how we use oxygen. Getting this right is the difference between rescuing a patient and, occasionally, harming them.
Two types of respiratory failure
Low oxygen alone, versus low oxygen with high carbon dioxide. In type 1 respiratory failure, the problem is purely low oxygen — the lung can't oxygenate the blood properly (as in pneumonia or a severe asthma attack), but carbon dioxide is being cleared normally or is even low. The treatment is straightforward: give oxygen to correct the low level, aiming for a normal target saturation. Type 2 respiratory failure is different and trickier: here the lung also can't clear carbon dioxide, so oxygen is low AND carbon dioxide is high — the classic setting is advanced COPD. This second type is where oxygen must be handled with care. Why? In some of these patients, breathing has become partly driven by the low oxygen itself, and their system tolerates a chronically high carbon dioxide. If you flood them with high-flow oxygen, you can remove that drive and disturb the delicate balance, allowing carbon dioxide to climb even higher — making them drowsy, then unconscious, and worsening the failure. So in type 2 failure, oxygen is given in a controlled, lower-target way: enough to keep them safe, but not so much that the carbon dioxide runs away. This is the 'controlled oxygen' rule flagged in the last article, and it's one of the most important safety concepts in respiratory care.
Long-term oxygen and respiratory stimulants
Beyond emergencies, oxygen has a life-prolonging role in chronic disease. In advanced COPD with persistently low blood oxygen, long-term oxygen therapy (LTOT) — oxygen used at home for many hours a day — is one of the few treatments actually shown to prolong survival. It's prescribed carefully, based on measured blood oxygen, and famously must not be used near cigarettes (oxygen vigorously supports combustion — a real fire risk). Two final, smaller topics round out respiratory support. Respiratory stimulants like doxapram are drugs that push the brain to breathe harder; they have a limited, niche role — occasionally used to buy time in type 2 respiratory failure when ventilation isn't available or appropriate — but they've largely been replaced by non-invasive ventilation (the assisting mask from the last article), which is safer and more effective. And it's worth flagging the mirror-image problem from other chapters: several drugs can DEPRESS breathing, most importantly opioids (from the CNS chapter) and sedatives, which is why they're used cautiously in anyone with respiratory disease. So oxygen and breathing support complete the acute-care picture: give oxygen as the drug it is — with the right target — and remember that in type 2 failure, more is not always better.
- Oxygen is a drug — prescribe it with a target saturation, a device and a reason.
- Type 1 failure = low oxygen only (e.g. pneumonia) → give oxygen to a normal target.
- Type 2 failure = low oxygen + HIGH CO2 (advanced COPD) → CONTROLLED, lower-target oxygen.
- Too much oxygen in type 2 can worsen CO2 retention → drowsiness and worsening failure.
- Long-term home oxygen prolongs life in advanced COPD (no smoking!); doxapram is a niche stimulant.
The idea that oxygen can be harmful is deeply counter-intuitive, and it's exactly why it deserves respect as a drug. For a patient in type 1 failure — pneumonia, an asthma attack — oxygen is purely good, and you give plenty. But for some patients in type 2 failure from advanced COPD, drowning them in oxygen can let carbon dioxide climb dangerously and tip them into a coma. The lesson isn't 'oxygen is dangerous'; it's that oxygen has a correct dose, and the correct dose depends on the type of respiratory failure. Prescribing it thoughtfully — with a target saturation rather than 'as much as possible' — is a genuine clinical skill, and a reminder that even the most fundamental substance in the body follows the first rule of pharmacology: the dose makes the medicine, and the poison.
- Giving high-flow oxygen to a type 2 (CO2-retaining) COPD patient — risk of worsening CO2 retention.
- Treating oxygen as harmless 'air' rather than a drug with a target and a dose.
- Using long-term oxygen near cigarettes — serious fire risk.
- Forgetting that opioids and sedatives depress breathing — caution in respiratory disease.
In which situation must oxygen be given cautiously, at a controlled lower target?
- Oxygen is a drug: prescribe a target saturation, a device and a reason.
- Type 1 failure (low O2 only) → give oxygen freely; type 2 (low O2 + high CO2) → controlled, lower target.
- Too much oxygen in type 2 can worsen CO2 retention and consciousness.
- Long-term home oxygen prolongs life in advanced COPD (no smoking!); doxapram is a niche stimulant.
- Katzung BG. Basic & Clinical Pharmacology — Respiratory support & pulmonary drugs.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Therapeutic gases: oxygen.
- BTS — Guideline for oxygen use in healthcare and emergency settings.
- GOLD — Global Initiative for Chronic Obstructive Lung Disease (oxygen therapy).
